Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$222,254,988
+$8,240,925 QoQ
Shares Held
875,123
-0.0% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#189
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ZACKS INVESTMENT MANAGEMENT holds $890,953,075 across 8 Drug Manufacturers - General names. JNJ ranks #1 (24.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
875,123 | $222,254,988 | |
| 2 | ABBV |
AbbVie Inc.
|
815,433 | $205,195,560 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,087,644 | $139,762,254 | |
| 4 | LLY |
ELI LILLY & Co
|
114,449 | $137,273,575 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
530,870 | $67,070,115 | |
| 6 | PFE |
Pfizer Inc
|
2,658,388 | $64,013,983 | |
| 7 | AMGN |
Amgen Inc
|
96,618 | $34,987,310 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
353,962 | $20,395,290 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $222,254,988 | 875,123 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $214,014,063 | 875,528 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $183,031,960 | 884,426 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $164,497,948 | 887,164 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $134,153,909 | 878,258 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $144,511,815 | 871,393 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $119,684,041 | 827,576 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $155,001,152 | 956,443 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $126,261,339 | 863,857 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $131,475,189 | 831,122 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $123,963,628 | 790,887 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $130,353,405 | 836,940 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $138,983,502 | 839,678 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $128,257,075 | 827,465 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $138,519,390 | 784,146 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $123,279,787 | 754,651 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $131,182,197 | 739,013 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $123,125,580 | 694,722 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $113,460,295 | 663,239 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $105,201,261 | 651,401 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $104,483,544 | 634,233 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $98,952,505 | 602,084 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $103,614,585 | 658,372 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $100,687,395 | 676,299 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $91,611,304 | 651,435 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $88,837,165 | 677,474 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||